ISB News

New Baliga Article: ‘The Promise of Systems Biology’

ISB Director and SVP Dr. Nitin Baliga contributed an article to the Missoulian Newspaper that explains the power of the systems biology approach to research. Read the full article…

“Biology is complex. The need to understand this complexity drives advancements in technologies that are required to measure properties of all of the constituent parts and to understand how they interact with one another. The application of those technologies generates large amounts of data, which are analyzed using algorithms or models run on computers. In doing so, new discoveries are made, and we move another step closer to understanding how dysfunction at the molecular level results in complex disease. Through this process, a systems biology approach can provide the knowledge required to personalize therapy based on a person’s specific genetic make-up, enabling doctors to target and tailor treatment to the uniqueness of every individual.”

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.